Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 85-95
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.85
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.85
Figure 1 Total number of 30 d readmissions of Crohn’s disease and ulcerative colitis.
Figure 2 Trends of 30 d readmission following Crohn’s disease and ulcerative colitis hospitalizations.
CDACR: Crohn’s disease all-cause readmission; UCACR: Ulcerative colitis all-cause readmission; CDSR: Crohn’s disease specific readmission; UCSR: Ulcerative colitis specific readmission.
- Citation: Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022; 13(3): 85-95
- URL: https://www.wjgnet.com/2150-5330/full/v13/i3/85.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i3.85